NASHVILLE, Tenn. / Jun 26, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 2Q Earnings Release Call |
When: | Thursday, July 27, 2023 at 9:00 am central (10:00 am eastern) |
How: | Live Audio over the Internet: |
https://investor.hcahealthcare.com/events-and-presentations/default.aspx | |
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$327.09 |
| Daily Change: | -0.54 -0.16 |
| Daily Volume: | 307,757 |
| Market Cap: | US$82.850B |
October 25, 2024 October 17, 2024 July 23, 2024 April 26, 2024 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
